✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

If you have decided to take HIV pre-exposure prophylaxis (PrEP), the next question is which PrEP medication to actually buy. The two molecules in the global PrEP toolkit are tenofovir + emtricitabine — sold under the originator brand Truvada (TDF/FTC) and the newer Descovy (TAF/FTC) — and the long-acting injectable cabotegravir sold as Apretude. The patents on Truvada have expired, and there are now eight WHO-GMP certified generic versions producing the same active ingredients at a fraction of the originator price. This guide walks through the 8 best PrEP medications available in 2026, including the newer TAF formulation that reduces kidney/bone effects and the protection bundles that pair PrEP with adjacent STD prevention.

Best PrEP Medications (2026): 8 Top HIV Pre-Exposure Prophylaxis Picks Compared

Last updated: April 27, 2026 · Reviewed by the MedsBase Medical Team

What PrEP Is and How It Works

PrEP (pre-exposure prophylaxis) is the use of antiretroviral medication by HIV-negative individuals to prevent HIV acquisition. The standard PrEP regimen pairs two nucleoside-analog reverse transcriptase inhibitors — tenofovir (in either TDF or TAF form) and emtricitabine — into a single daily tablet. When taken consistently, daily oral PrEP reduces the risk of HIV acquisition by ~99% from sexual exposure and ~74% from injection-drug exposure (the difference reflects different pharmacokinetics in different tissues).

PrEP is one of the most studied HIV prevention strategies in the modern era, with major trials including iPrEx (men who have sex with men), Partners PrEP (heterosexual sero-discordant couples), TDF2 (heterosexual adults), Bangkok Tenofovir Study (people who inject drugs), and the more recent DISCOVER (TAF/FTC) trial. The headline finding across all of them is the same: when adherence is ≥95%, HIV acquisition is rare to essentially absent.

What PrEP does and does not protect against: PrEP is HIV-specific. It does not protect against gonorrhoea, chlamydia, syphilis, mpox, hepatitis A/B/C, or unwanted pregnancy. Combining PrEP with regular STD testing (every 3 months while on PrEP) and condoms remains the gold-standard sexual-health strategy. Hepatitis B status must be checked before starting PrEP — both tenofovir and emtricitabine have anti-hepatitis-B activity, and stopping either drug abruptly in someone with chronic hepatitis B can trigger a hepatitis flare.

TDF vs TAF — The Critical Choice

The single most important decision in choosing a PrEP brand is whether to use tenofovir disoproxil fumarate (TDF) — the older form found in Truvada generics like Tenvir EM, Ricovir EM, and Tenof EM — or tenofovir alafenamide (TAF) — the newer form found in Descovy and its generic equivalent Tenvir AF.

Both are pro-drugs of the same active molecule (tenofovir diphosphate) and both achieve equivalent HIV-prevention efficacy when taken daily. The clinical difference is in the off-target effects:

Practical translation: if you have normal kidney function, normal bone density, and no specific reason to prefer TAF, generic TDF/FTC (Tenvir EM, Ricovir EM, Tenof EM) is clinically excellent and substantially cheaper. If you have reduced kidney function (eGFR 30–60 ml/min), known osteoporosis or osteopenia, or are over ~50 with bone-density risk factors, the lower off-target tenofovir exposure of TAF (Tenvir AF) is worth the price premium. The on-demand “2-1-1” dosing schedule is supported by trial data only for TDF/FTC, not for TAF/FTC — if you plan to use on-demand PrEP, choose a TDF/FTC brand.

The 8 Best PrEP Medications — Reviewed

The picks below cover five WHO-GMP-certified TDF/FTC generic Truvada brands, one TAF/FTC alternative, the tenofovir 300 mg standalone (for context), and a sexual-health protection bundle.

1. Tenvir EM — Best Overall Generic Truvada (TDF/FTC)

Tenvir EM contains 300 mg of tenofovir disoproxil fumarate (TDF) plus 200 mg of emtricitabine (FTC) in a single daily tablet — the same active ingredients and same doses as Gilead’s original Truvada. It is manufactured by Cipla and is the most widely-recognised generic PrEP brand on the international market. One tablet daily, with or without food.

This is the right pick for the majority of first-time PrEP users: Cipla’s manufacturing footprint means consistent availability across regions, the brand is widely-known by clinicians worldwide, and the per-month price is far below originator Truvada. If you have no specific reason to prefer TAF (Tenvir AF) or another generic, start here.

2. Ricovir EM — Best Budget TDF/FTC Generic

Ricovir EM is Mylan/Viatris’s TDF/FTC generic — same molecules, same doses, same WHO-GMP standard as Tenvir EM, typically at one of the lower price points in the TDF/FTC range. Pharmacologically interchangeable with Tenvir EM. The differentiator is purely commercial.

Choose Ricovir EM when cost per month is the primary constraint and you want to stock several months of daily use. PrEP is a long-haul daily medication — the cumulative price difference between brands matters over years.

3. Tenof EM — Alternative TDF/FTC Generic

Tenof EM rounds out the budget TDF/FTC options. We list multiple generic Truvada brands because regional availability fluctuates per ship-to country — having three WHO-GMP-equivalent options means we rarely have to redirect a customer to a different molecule entirely.

If your existing supplier ships Tenof EM and you have used it before, stay with what works. If you are new to PrEP, the three TDF/FTC brands (Tenvir EM, Ricovir EM, Tenof EM) are clinically interchangeable — pick on price.

4. Tavin EM — Newer Generic TDF/FTC Option

Tavin EM is a newer entrant to the generic Truvada market, manufactured to the same WHO-GMP pharmacopeial standards. Same molecule, same dose, same once-daily schedule. Pick Tavin EM when it is the in-stock option at your preferred price point.

5. Taficita — Alternative WHO-GMP TDF/FTC Brand

Taficita is another TDF/FTC generic with the same active ingredients and dose schedule as the four above. The TDF/FTC PrEP regimen is one of the most commoditised antiretroviral combinations globally, which is why we stock five interchangeable brands — each represents a different generic manufacturer’s supply chain into different regions.

6. Tenvir AF — Best TAF/FTC Option (Lower Kidney/Bone Effects)

Tenvir AF contains tenofovir alafenamide (TAF) — the newer pro-drug form of tenofovir — plus emtricitabine. Plasma tenofovir exposure is roughly 90% lower than with TDF, which translates to measurably less impact on kidney function and bone mineral density in long-term use. HIV-prevention efficacy is equivalent to TDF/FTC at ≥95% adherence.

This is the right pick if (a) baseline eGFR is 30–60 ml/min (TDF is contraindicated below 30, and TAF allows PrEP down to 30), (b) you have known osteoporosis or osteopenia, (c) you are over 50 with bone-density risk factors, or (d) you have had bothersome renal effects on TDF generics. The trade-offs are higher price per month and limited evidence for the on-demand “2-1-1” schedule (so stick to daily dosing on TAF). TAF also produces small increases in LDL cholesterol and modest weight gain in some users, where TDF is largely neutral or weight-favourable.

7. Tenvir — Tenofovir 300 mg Standalone

Tenvir is tenofovir disoproxil fumarate 300 mg by itself, without the emtricitabine component. Tenofovir alone is rarely used for PrEP in modern practice — the TDF/FTC combination has substantially better evidence for HIV prevention and the additional cost of FTC is small. The Bangkok Tenofovir Study did show some efficacy with TDF alone in people who inject drugs, but the FDA, WHO, and most national guidelines now recommend the combination.

This product is included on the list because (a) it is the building block of the TDF/FTC combination products, (b) some users use it alongside lamivudine for hepatitis B, and (c) it is occasionally used as part of fully-customised antiretroviral regimens under specialist care. For PrEP specifically, choose a TDF/FTC combination product (Tenvir EM, Ricovir EM, Tenof EM, Tavin EM, Taficita) instead.

8. STD Protection Pack — Bundle for Broader Sexual-Health Coverage

STD Protection Pack bundles PrEP with adjacent sexual-health medication for users seeking broader STD coverage in one order. PrEP itself is HIV-specific; this pack adds the auxiliary prevention layer for users at higher risk of bacterial STDs alongside HIV exposure.

Pick the protection pack when you want a simpler one-order approach to broader sexual-health coverage. For HIV prevention specifically, any of the TDF/FTC or TAF/FTC products above is sufficient on its own.

At-a-Glance Comparison Table

This is the centrepiece of the guide. Use this table to map your priority — TDF vs TAF, daily vs on-demand, monotherapy vs combination, generic vs originator equivalent — to the right pick.

Browse the full catalogue on the PrEP medication category page, or see our broader HIV medication category for treatment regimens.

How to Choose the Right PrEP

The single most useful question to ask yourself is “do I have any reason to need TAF instead of TDF?” Everything else flows from that.

A common mistake is assuming TAF is universally “better” than TDF. For HIV prevention efficacy, they are equivalent. The choice between them is about off-target effects (kidney, bone, lipids, weight) and dosing flexibility (TDF supports on-demand “2-1-1”, TAF does not have the same evidence base for it). For most users with normal kidney and bone status, the cheaper TDF/FTC generics are clinically excellent.

Daily vs On-Demand Dosing (and Monitoring)

There are two evidence-based PrEP dosing schedules:

Daily PrEP — one tablet every day at roughly the same time, regardless of when sexual exposure happens. This is the default recommendation across CDC, WHO, BHIVA, and EACS guidelines. It works for any pattern of sexual exposure, including transactional sex, frequent encounters, and any sexual activity in trans women. Both TDF/FTC and TAF/FTC are licensed for daily use.

On-demand “2-1-1” — two tablets 2–24 hours before sex, one tablet 24 hours after the first dose, and one more tablet 48 hours after the first dose. Established by the French IPERGAY trial in cisgender men who have sex with men (MSM). Suitable for users whose sexual exposures are infrequent and predictable. Evidence base supports TDF/FTC only — not TAF/FTC. Not recommended for vaginal sex (different tissue pharmacokinetics; daily dosing is safer for cisgender women and trans men with cervico-vaginal exposure).

Side Effects, Interactions & Safety

PrEP is one of the most well-tolerated medication classes in modern preventive medicine. The brief safety picture:

Common (mild and usually transient): nausea, headache, mild GI upset in the first 1–4 weeks of starting (sometimes called the “start-up syndrome”). Symptoms generally resolve as the body adjusts. Take with food if upset is bothersome.

Less common but worth knowing on TDF: small, slow decline in kidney function (eGFR drops a few ml/min); small decline in bone mineral density. Both reverse within months of discontinuation. The clinical relevance is highest in people who already have impaired baseline function — which is why TAF/FTC (Tenvir AF) is the preferred alternative for that group.

HIV resistance risk: the only setting where PrEP can cause harm rather than just lack of benefit is if it is started during undiagnosed acute HIV infection. Tenofovir + FTC monotherapy in acute HIV can select for resistance. This is why a 4th-generation HIV antibody/antigen test before starting PrEP is non-negotiable, and why some clinics also do an HIV RNA PCR if there has been very recent high-risk exposure (because antibody can be negative for up to 4 weeks while RNA is positive).

Hepatitis B: tenofovir and emtricitabine both have anti-HBV activity. If you have chronic hepatitis B, stopping PrEP abruptly can trigger an HBV flare. Test for HBsAg before starting PrEP; in HBV-positive users, plan PrEP discontinuation carefully with a clinician.

Frequently Asked Questions

What is the best PrEP medication?

For most users with normal kidney and bone function, Tenvir EM (Cipla’s generic Truvada — TDF 300 + FTC 200) is the standard first-line PrEP medication: ~99% efficacy at ≥95% adherence, supported for both daily and on-demand “2-1-1” dosing, and substantially cheaper than originator Truvada. Tenvir AF (TAF/FTC) is the better choice if you have reduced kidney function, low bone density, or are over 50 with bone-density risk factors.

What is the difference between TDF and TAF?

Both TDF and TAF are pro-drugs of tenofovir and have equivalent HIV-prevention efficacy when taken daily. TAF achieves the same active intracellular drug concentration with ~90% lower plasma tenofovir exposure, which translates to less impact on kidney function and bone mineral density. Trade-offs: TAF is more expensive, has limited evidence for the on-demand “2-1-1” schedule, and produces small lipid increases and modest weight gain in some users.

Which generic Truvada brand is best?

Tenvir EM (Cipla) is the most-recognised generic Truvada and the standard pick. Ricovir EM (Mylan/Viatris) is typically the cheapest. Tenof EM, Tavin EM, and Taficita are clinically interchangeable WHO-GMP alternatives. Pick on price or on which brand your supplier ships reliably — the active ingredients and doses are identical.

Can I take PrEP on demand instead of daily?

Yes, if you use a TDF/FTC product (Tenvir EM, Ricovir EM, Tenof EM, Tavin EM, Taficita) and your sexual exposures fit the “2-1-1” pattern: two tablets 2–24 hours before sex, one tablet 24 hours after the first dose, one more tablet 48 hours after the first dose. The IPERGAY trial established this for cisgender MSM only. Daily dosing is safer for vaginal exposure (cervico-vaginal pharmacokinetics differ).

How long does PrEP take to be protective?

For sexual exposure via the rectum, daily TDF/FTC reaches reliably protective tissue concentrations after about 7 days of consistent dosing. For vaginal tissue, the timeline is slightly longer — 20 days of daily dosing — because tenofovir reaches lower concentrations in cervico-vaginal tissue. The on-demand “2-1-1” schedule front-loads with two tablets to compensate for the lack of build-up.

Is generic PrEP as effective as Truvada?

Yes. Tenvir EM, Ricovir EM, Tenof EM, Tavin EM, and Taficita all contain TDF 300 mg + FTC 200 mg manufactured to WHO-GMP pharmacopeial standards — the same active ingredients at the same doses as Gilead’s Truvada. The clinical effect is identical; the price is a fraction of the originator brand.

Do I need a prescription for PrEP?

PrEP is a prescription medication in most countries, but importation rules vary by region. Beyond the legal question, the medical preconditions matter regardless of how you obtain the medication: get a 4th-generation HIV antibody/antigen test before starting, check hepatitis B status, baseline kidney function, and arrange every-3-months follow-up testing while on PrEP. The follow-up monitoring is what makes PrEP safe — not the prescription paperwork.

What other STDs does PrEP protect against?

PrEP is HIV-specific. It does not protect against gonorrhoea, chlamydia, syphilis, mpox, hepatitis A/B/C, herpes, HPV, or unwanted pregnancy. The recommended pairing is PrEP + every-3-months STD testing + condoms for non-monogamous encounters. The STD Protection Pack bundles PrEP with adjacent STD prophylaxis for users wanting broader sexual-health coverage in one order.

Where can I buy these PrEP medications?

All eight products on this list are available on this site. Click through any of the brand links above to the relevant product page, or browse the full PrEP medication category. Worldwide shipping.

The Bottom Line

There is no universal “best” PrEP — there is the best PrEP for your situation. For most users, Tenvir EM (Cipla’s generic Truvada — TDF 300 + FTC 200) is the standard first-line pick: ~99% efficacy at ≥95% adherence, supported for both daily and on-demand “2-1-1” dosing, far cheaper than originator Truvada. From there, the useful upgrade paths are: switch to Ricovir EM or Tenof EM if cost is the primary constraint, switch to Tenvir AF if kidney function or bone density is reduced, or pick the STD Protection Pack for broader sexual-health coverage in one order.

The decision tree is small. Pick your tenofovir form (TDF vs TAF), pick your dosing schedule (daily vs on-demand), and pick the generic brand inside that class on price. Then run the 3-monthly testing schedule that makes long-term PrEP safe.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.